– Israel- and Palo Alto, California-based Metrolink.ai, which is developing a platform for data management, announced that it raised $22 million in a seed round led by Grove Ventures with participation from Eclipse Ventures.
– The company says that it’ll use the funds, which value Metrolink at $65 million post-money, to grow its R&D, marketing, and sales efforts and lay the groundwork for a U.S. expansion.
– Metrolink’s product aims to help enterprises build and deploy dataflow infrastructures using no-code visual dev tools.
– Data migration and transformation can present particular blockers in the enterprise.

– Reliable Robotics, a startup that is developing autonomous aircraft systems, raised $130m in Series C funding.
– The round was led by Coatue Management and joined by Lightspeed Ventures, Eclipse Ventures, Teamworthy Ventures and Pathbreaker Ventures.
– The company plans to use the funds to scale the team and support its first aircraft certification program.

– Rune Labs is a San Francisco, CA-based brain data company enabling the advancement and delivery of precision neuroscience therapeutics.
– The company raised $22.8m in Series A funding.
– The round was led by Eclipse Ventures with participation from current investors including DigiTx Partners and Moment Ventures.
– The new investment will be used to expand the number of patients, clinicians, and researchers using its platform.

- SafelyYou from San Francisco provides artificial intelligence-enabled fall detection and prevention for dementia care. - Series A $19.5m round was led by Eclipse Ventures with participation from Founders Fund, as well as existing investors DCVC, Foundation Capital, TSQ Advisors, Pathbreaker Ventures, The House Fund, Swift Ventures, Pacific Health Ventures, Anorak Ventures, and 7Percent Ventures. - The new investment will be used to scale up the business.

- SafelyYou from San Francisco provides artificial intelligence-enabled fall detection and prevention for dementia care. - Series A $19.5m round was led by Eclipse Ventures with participation from Founders Fund, as well as existing investors DCVC, Foundation Capital, TSQ Advisors, Pathbreaker Ventures, The House Fund, Swift Ventures, Pacific Health Ventures, Anorak Ventures, and 7Percent Ventures. - The new investment will be used to scale up the business.

– Third Wave Automation, Inc. is an Union City CA-based autonomous industrial solutions company.
– The company raised $40m in Series B funding.
– The round was led by Norwest Venture Partners with participation from prior investors Innovation Endeavors and Eclipse, along with Toyota Ventures.
– The new investment will be used to accelerate growth and commercialization efforts.

– Tenstorrent is a hardware startup developing next generation computers whose Grayskull processor will go to market in the second half of 2021.
– The company raised over $200M in funding round at a $1b valuation.
– The round was led by Fidelity Management and Research Company with participation from Eclipse Ventures, Epic CG and Moore Capital.
– The new investment will be used to continue creating AI focused hardware for developers.

– Chord Raises $18M In Series A Funding
– The round was led by Eclipse Ventures, which joined a roster of existing institutional investors including Foundation Capital, WhiteStar Capital, Forerunner Ventures, Index Ventures, and Thrive Capital, as well as angel investors from the commerce world, most notably Will Gaybrick of Stripe, and the founders of D2C brands such as Allbirds, Harry’s, and Warby Parker.
– The company intends to use the funds to develop more technology and data products, as well as to continue to grow.
– Bryan Mahoney is CEO and Henry Davis is Chairman & COO.
– Leslie Lorenz is joining the company as Vice President of Data.

– Flex Logix raised a $55M Series D financing round.
– The round was led by Mithril Capital Management with participation from existing investors Lux Capital, Eclipse Ventures, and the Tate Family Trust.
– Flex Logix’s inference architecture is unique. It is optimized for low latency operation required by edge megapixel vision applications.
– It combines numerous 1-dimensional tensor processors with reconfigurable, high bandwidth, non-blocking interconnect that enables each layer of the neural network model to be configured for maximum utilization, resulting in very high performance with less cost and power.
– The connections between compute and memory are reconfigured in millionths of a second as the model is processed.

– ForSight Robotics is developing a surgical robotic platform that will transform the future of ophthalmic surgery with a $10m seed round led by Eclipse Ventures and joined by Mithril Capital.
– The mission is to re-imagine ophthalmic surgery by applying the most advanced technologies in microsurgical robotics, computer visualization and machine learning.
– The platform will automate the complex subtleties of ophthalmic surgery with an intuitive, patient-centric system that tackles the profound and growing problems of preventable blindness and visual impairment.
– Many of the leading causes of blindness worldwide can be prevented with timely surgical procedures. However, ophthalmic microsurgery is intricate and challenging, requiring many years to master. Also, trained ophthalmic surgeons are in extremely short supply worldwide.

– Israel-based ForSight Robotics announced today that it has raised $10 million for what it has deemed a “mega-seed round.”
– The round was led by Eclipse Ventures and Mithril Capital, and will go toward expanding the company’s headcount and global reach, as it looks to bring its offerings to international markets, pending the sorts of regulatory approvals that go into launching a robotic surgery platform.
– The company’s surgical platform is designed specifically for ophthalmological (eye) surgeries — a category requiring a great deal of precision.
– It’s also one in great demand. The company cites a recent study from the British Journal of Ophthalmology, putting the number of qualified eye surgeons at around 72 per million people in developed nations and a mere 3.7 surgeons per million in developed countries.